Evidence map›Paper›PMID 25731872›Full record

ArticleGut2015

Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis.

Laurent Dubuquoy, Alexandre Louvet, Guillaume Lassailly, Stéphanie Truant, Emmanuel Boleslawski, Florent Artru, François Maggiotto, Emilie Gantier, David Buob, Emmanuelle Leteurtre and 6 more

Open access · greenAbstract read
In one paragraph

Article in Gut, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 2 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 2 syntheses or guidelines pooled it, 174 citations in OpenAlex.

  1. Pooled it
  2. ACG Clinical Guideline: Alcoholic Liver Disease.The American journal of gastroenterology · 2018
    Guideline
  3. Article
  4. Article
  5. Chronic Cholestatic Liver Disease Induced by Larval Ascariasis: Novel Insights Into Immune-Mediated Pathogenesis and Hepatic Fibrosis in Mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Cholestasis in Alcohol-Associated Liver Disease.The American journal of pathology · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. In vitro liver models for toxicological research.Drug metabolism and pharmacokinetics · 2025
    Review
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Laurent DubuquoyInserm, UMR995 - LIRIC, Lille, France Univ Lille, UMR995 - LIRIC, Lille, France CHRU Lille, Service des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Huriez, Lille, France.ORCID http://orcid.org/0000-0003-3596-5497
Alexandre LouvetInserm, UMR995 - LIRIC, Lille, France Univ Lille, UMR995 - LIRIC, Lille, France CHRU Lille, Service des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Huriez, Lille, France.
Guillaume LassaillyInserm, UMR995 - LIRIC, Lille, France Univ Lille, UMR995 - LIRIC, Lille, France CHRU Lille, Service des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Huriez, Lille, France.
Stéphanie TruantCHRU Lille, Service de Chirurgie Digestive et Transplantation, Hôpital Huriez, Lille, France.
Emmanuel BoleslawskiCHRU Lille, Service de Chirurgie Digestive et Transplantation, Hôpital Huriez, Lille, France.
Florent ArtruInserm, UMR995 - LIRIC, Lille, France Univ Lille, UMR995 - LIRIC, Lille, France CHRU Lille, Service des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Huriez, Lille, France.
François MaggiottoInserm, UMR995 - LIRIC, Lille, France Univ Lille, UMR995 - LIRIC, Lille, France CHRU Lille, Service des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Huriez, Lille, France.
Emilie GantierInserm, UMR995 - LIRIC, Lille, France Univ Lille, UMR995 - LIRIC, Lille, France CHRU Lille, Service des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Huriez, Lille, France.
David BuobCHRU Lille, Service d'Anatomo-Pathologie, Lille, France.
Emmanuelle LeteurtreCHRU Lille, Service d'Anatomo-Pathologie, Lille, France.
Amélie CannessonInserm, UMR995 - LIRIC, Lille, France Univ Lille, UMR995 - LIRIC, Lille, France CHRU Lille, Service des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Huriez, Lille, France.
Sébastien DharancyInserm, UMR995 - LIRIC, Lille, France Univ Lille, UMR995 - LIRIC, Lille, France CHRU Lille, Service des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Huriez, Lille, France.
Christophe MorenoDepartment of Gastroenterology and Hepato-pancreatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Brussels, Belgium.
François-René PruvotCHRU Lille, Service de Chirurgie Digestive et Transplantation, Hôpital Huriez, Lille, France.
Ramon BatallerDepartment of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA.
Philippe MathurinInserm, UMR995 - LIRIC, Lille, France Univ Lille, UMR995 - LIRIC, Lille, France CHRU Lille, Service des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Huriez, Lille, France.
Inserm · FRHôpital Claude Huriez · FRCentre Hospitalier Universitaire de Lille · FRUniversité Libre de Bruxelles · BEUniversity of North Carolina at Chapel Hill · US

Funding

Molecular Subtypes for Targeted Therapies in Alcoholic HepatitisU01AA021908 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BATALLER, RAMON · 2013 to 2017
$6.0M
MIF in progression and treatment of ALDU01AA020821 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI NAGY, LAURA E. · 2012 to 2016
$2.1M
NIAAA NIH HHS 1U01AA021908-01NIAAA NIH HHS U01 AA020821NIAAA NIH HHS U01 AA021908
6 · The paper itself

Abstract

objectiveIn alcoholic hepatitis (AH), development of targeted therapies is crucial and requires improved knowledge of cellular and molecular drivers in liver dysfunction. The unique opportunity of using explanted livers from patients with AH having undergone salvage liver transplantation allowed to perform more in-depth molecular translational studies.

designWe studied liver explants from patients with AH submitted to salvage transplantation (n=16), from patients with alcoholic cirrhosis without AH (n=12) and fragments of normal livers (n=16). Hepatic cytokine content was quantified. Hepatocyte function and proliferation and the presence of hepatic progenitor cells (HPCs) were evaluated by immunohistochemistry, western blot or quantitative PCR. Mitochondrial morphology was evaluated by electron microscopy.

resultsLivers from patients with AH showed decreased cytokine levels involved in liver regeneration (tumour necrosis factor α and interleukin-6), as well as a virtual absence of markers of hepatocyte proliferation compared with alcoholic cirrhosis and normal livers. Electron microscopy revealed obvious mitochondrial abnormalities in AH hepatocytes. Importantly, livers from patients with AH showed substantial accumulation of HPCs that, unexpectedly, differentiate only into biliary cells. AH livers predominantly express laminin (extracellular matrix protein favouring cholangiocyte differentiation); consequently, HPC expansion is inefficient at yielding mature hepatocytes.

conclusionsAH not responding to medical therapy is associated with lack of expression of cytokines involved in liver regeneration and profound mitochondrial damage along with lack of proliferative hepatocytes. Expansion of HPCs is inefficient to yield mature hepatocytes. Manoeuvres aimed at promoting differentiation of HPCs into mature hepatocytes should be tested in AH.

Indexed as

Cell DifferentiationCell ProliferationCytokine TWEAKDNA DamageDNA, MitochondrialHepatitis, AlcoholicHepatocytesHumansInterleukin-6Keratin-7Ki-67 AntigenLamininLiverLiver Cirrhosis, AlcoholicLiver RegenerationMitochondriaCytokine TWEAKDNA, MitochondrialInterleukin-6Keratin-7Ki-67 AntigenLamininNF-kappa BTNFSF12 protein, humanTumor Necrosis Factor-alphaTumor Necrosis FactorsALCOHOLIC LIVER DISEASECYTOKERATINSEXTRACELLULAR MATRIXHEPATOCYTELIVER REGENERATION

Identifiers

PMID25731872
PMCPMC4558407
OpenAlexW1978594622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.